{"id":323813,"date":"2026-10-22T12:46:52","date_gmt":"2026-10-22T07:16:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=323813"},"modified":"2026-10-22T12:46:52","modified_gmt":"2026-10-22T07:16:52","slug":"branded-generics-fermentation-based-ingredients-and-latin-america-generics-stocks-roadmap-harbinger-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/branded-generics-fermentation-based-ingredients-and-latin-america-generics-stocks-roadmap-harbinger-list\/","title":{"rendered":"3 Branded Generics, Fermentation-Based Ingredients and Latin America Generics Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories"},"content":{"rendered":"

Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories: ROE of 12.9% to 18.7% and FY22 to FY26 revenue CAGR of 10.7% to 15.2%. Prices as of 21 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three branded generic and ingredient stocks to watch are Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories. Their return on equity ranges from 12.9% to 18.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.7% to 15.2%. Emcure Pharmaceuticals has the highest return on equity at 18.7%, while Caplin Point Laboratories has the fastest revenue growth at 15.2% a year. Prices are based on the 21 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Branded generic and ingredient stocks let investors follow companies with distinct routes into pharma markets. Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories cover branded generics, fermentation-based ingredients, and generics for Latin America and other emerging markets.<\/p>\n

This list covers three branded generic and ingredient stocks with complete current figures: Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories. Every figure comes from the latest reported financials and the 21 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n